Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 158

The DOI matches its Crossref record.

Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial

Open access
Falconer, Henrik, Palsdottir, Kolbrun, Stalberg, Karin, Dahm-Kähler, Pernilla, Ottander, Ulrika, Lundin, Evelyn Serreyn, Wijk, Lena, Kimmig, Rainer, Jensen, Pernille Tine, Zahl Eriksson, Ane Gerda, Mäenpää, Johanna, Persson, Jan, Salehi, Sahar · 2019 · International Journal of Gynecological Cancer

Abstract

Background Radical hysterectomy with pelvic lymphadenectomy represents the standard treatment for early-stage cervical cancer. Results from a recent randomized controlled trial demonstrate that minimally invasive surgery is inferior to laparotomy with regards to disease-free and overall survival. Primary Objective To investigate the oncologic safety of robot-assisted surgery for early-stage cervical cancer as compared with standard laparotomy. Study Hypothesis Robot-assisted laparoscopic radical hysterectomy is non-inferior to laparotomy in regards to recurrence-free survival with the advantage of fewer post-operative complications and superior patient-reported outcomes. Trial Design Prospective, multi-institutional, international, open-label randomized clinical trial. Consecutive women with early-stage cervical cancer will be assessed for eligibility and subsequently randomized 1:1 to either robot-assisted laparoscopic surgery or laparotomy. Institutional review board approval will be required from all participating institutions. The trial is coordinated from Karolinska University Hospital, Sweden. Major Inclusion/Exclusion Criteria Women over 18 with cervical cancer FIGO (2018) stages IB1, IB2, and IIA1 squamous, adenocarcinoma, or adenosquamous will be included. Women are not eligible if they have evidence of metastatic disease, serious co-morbidity, or a secondary invasive neoplasm in the past 5 years. Primary Endpoint Recurrence-free survival at 5 years between women who underwent robot-assisted laparoscopic surgery versus laparotomy for early-stage cervical cancer. Sample Size The clinical non-inferiority margin in this study is defined as a 5-year recurrence-free survival not worsened by >7.5%. With an expected recurrence-free survival of 85%, the study needs to observe 127 events with a one-sided level of significance (α) of 5% and a power (1−β) of 80%. With 5 years of recruitment and 3 years of follow-up, the necessary number of events will be reached if the study can recruit a total of 768 patients. Estimated Dates for Completing Accrual and Presenting Results Trial launch is estimated to be May 2019 and the trial is estimated to close in May 2027 with presentation of data shortly thereafter. Trial Registration The trial is registered at ClinicalTrials.gov (NCT03719547).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/ijgc-2019-000558

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 158

Metadata

Authors
Falconer, H., Palsdottir, K., Stalberg, K., Dahm-Kähler, P., Ottander, U., Lundin, E. S., Wijk, L., Kimmig, R., Jensen, P. T., Zahl Eriksson, A. G., Mäenpää, J., Persson, J., & Salehi, S.
Venue
International Journal of Gynecological Cancer
Publisher
Elsevier BV
Published
2019-07
Volume
29
Issue
6
Pages
1072-1076
ISSN
1048-891X (ISSN-L)
OpenAlex
W2952254139
Cited by
158
References
0
FWCI
17.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial. https://app.cochat.ai/papers/10.1136/ijgc-2019-000558
The paper
Falconer, H., Palsdottir, K., Stalberg, K., Dahm-Kähler, P., Ottander, U., Lundin, E. S., Wijk, L., Kimmig, R., Jensen, P. T., Zahl Eriksson, A. G., Mäenpää, J., Persson, J., & Salehi, S. (2019). Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial. International Journal of Gynecological Cancer. https://doi.org/10.1136/ijgc-2019-000558

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.